Receptor mediated murine leukemogenesis: monoclonal antibody induced lymphoma cell growth arrest.
نویسندگان
چکیده
We have proposed a receptor-mediated leukemogenesis hypothesis wherein T lymphomas would be clones of T cells bearing mitogen-linked surface receptors specific for the envelope determinants of the inducing MuLV (Weissman and Baird 1977; McGrath and Weissman 1978, 1979). We have tested a wide range of murine thymic lymphomas induced by thymotropic retroviruses and have shown that these cells indeed bear surface receptors highly specific for the retrovirus envelope glycoproteins produced by these cells (McGrath et al. 1978a,b). Even closely related recombinant retroviruses bound less well than the autologous retroviruses (McGrath et al. 1978b, McGrath and Weissman 1979). That these retroviruses and their interactions with T lymphoma cell receptors might be involved in the pathogenesis of murine leukemia was suggested by two kinds of experiments: First, only the leukemogenic viral isolates bouJ?-d specifically to lymphoma cel1 receptors, while nonleukemogenic but closely related viral preparations bound less weIl or not at all (McGrath et al. 1978b, McGrath and Weissman 1979). Second, if one examined the distribution of receptor bearing cells in the thymus of a preleukemic AKR mouse, only T cells bearing cell surface receptors recognizing the inducing MuLV were capable of adoptive transfer of the leukemic state, whereas morphologically similar cells within the same thymus were not capable of leukernic proliferation in syngeneic hosts (McGrath and Weissman 1978, 1979). While the above described experimental results are consistent with the receptor-mediated leukemogenesis hypo thesis and in fact were necessary postulates of the hypothesis
منابع مشابه
Immunostimulatory oligodeoxynucleotides containing CpG motifs enhance the efficacy of monoclonal antibody therapy of lymphoma.
Bacterial DNA and synthetic oligodeoxynucleotides containing the CpG motif (CpG ODN) can activate various immune cell subsets, including natural killer cells and macrophages. We evaluated whether the combination of CpG ODN and antitumor monoclonal antibody is effective at preventing tumor growth in an immunocompetent murine lymphoma model. CpG ODN-activated murine splenocytes induced lysis of t...
متن کاملTargeting autocrine and paracrine VEGF receptor pathways inhibits human lymphoma xenografts in vivo.
The role of angiogenesis in lymphoproliferative diseases is not well established. We demonstrate here that human lymphoma cells secrete vascular endothelial growth factor (VEGF) and express VEGF receptor 1 (VEGFR-1) and VEGFR-2. Proliferation of non-Hodgkin lymphoma (NHL) cells under serum-free conditions was enhanced by the addition of VEGF and was blocked by VEGFR-1- and VEGFR-2-specific anti...
متن کاملEffective therapy for a murine model of human anaplastic large-cell lymphoma with the anti-CD30 monoclonal antibody, HeFi-1, does not require activating Fc receptors.
CD30 is a member of the tumor necrosis factor receptor family. Overexpression of CD30 on some neoplasms versus its limited expression on normal tissues makes this receptor a promising target for antibody-based therapy. Anaplastic large-cell lymphoma (ALCL) represents a heterogeneous group of aggressive non-Hodgkin lymphomas characterized by the strong expression of CD30. We investigated the the...
متن کاملThe human anti-CD30 antibody 5F11 shows in vitro and in vivo activity against malignant lymphoma.
CD30 is a promising target for antibody-based immunotherapy of Hodgkin lymphoma (HL) and anaplastic large cell lymphoma. To overcome the limitations from currently available murine anti-CD30 monoclonal antibodies (mAbs), a new fully human anti-CD30 antibody was generated. Binding properties were evaluated by recombinant CD30 capture enzyme-linked immunosorbent assay (ELISA) and fluorescence-act...
متن کاملتولید آنتی بادی تک زنجیرهای انسانی شده ضد مارکر CD20 در E.coli
Background and Objectives: Rituximab is an anti-CD20 chimeric monoclonal antibody widely used for the treatment of malignant B cells lymphoma. However, the immunogenicity of murine-derived monoclonal antibodies and the large size of full length antibodies restrict cancer immunotherapy. Humanized single chain antibodies can be a solution and a promising alternative for application in immunothera...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Haematology and blood transfusion
دوره 26 شماره
صفحات -
تاریخ انتشار 1981